Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4841890

Cc1ccccc1-c1nc2cc(Br)cnc2[nH]1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 2/20 0.46
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PDE2A O00408 1/20 0.39
SLC9A1 P19634 2/20 0.39
NPBWR1 P48145 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
KDM5A P29375 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
KDM5B Q9UGL1 1/20 0.37
MAPK10 P53779 1/20 0.36
KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20708511 0.88 PTGES (0.55) PTGESALDH1A1NPC1HPGDHTT
Trifluoroacetic Acid SCHEMBL4844656 0.88 PTGES (0.47) PTGESALDH1A1HPGDHDAC3HDAC7
Trifluoroacetic Acid SCHEMBL4843458 0.86 PDE5A (0.43) SLC9A1HDAC6FGFR2
SCHEMBL4844661 0.79 PDE5A (0.37) PTGESNPSR1HDAC3HDAC7HDAC10
Trifluoroacetic Acid SCHEMBL4843644 0.78 PIN1 (0.49) PDE2ASLC9A1HDAC3HDAC6
Trifluoroacetic Acid SCHEMBL4842729 0.77 AURKA (0.52) NPC1RAB9APDE2A
Trifluoroacetic Acid SCHEMBL4834909 0.77 HDAC6 (0.47) ALDH1A1HPGDSMN1; SMN2PDE2AHDAC3
Trifluoroacetic Acid SCHEMBL4842876 0.77 CHEK2 (0.45) ALDH1A1NPC1RAB9ASMN1; SMN2
Trifluoroacetic Acid SCHEMBL5262965 0.77 PIN1 (0.51) ALDH1A1SLC9A1HDAC6
Trifluoroacetic Acid SCHEMBL5260040 0.76 ALDH1A1 (0.48) ALDH1A1NPC1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 PTGES 1862/4885ALDH1A1 1489/4885NPC1 2655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.